After Hours
$
1.35
Change
0.00 0.00%
Volume
Volume 648
May 20, 2022, 4:00 p.m.
Quotes are delayed by 20 min
Today's close
$ 1.43
$ 1.35
Change
-0.08 -5.59%
Day low
Day high
$1.33
$1.45

52 week low
52 week high
$1.16
$12.95

Market cap
$61.81M
Average volume
266,700
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-1.58
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on GMTX
-
Gemini Therapeutics started at buy with $20 stock price target at Stifel Nicolaus
- Tomi Kilgore
Other News on GMTX
-
10-Q: GEMINI THERAPEUTICS, INC. /DE
- Edgar Online - (EDG = 10Q, 10K)
-
Amicus Therapeutics Among Small Biotechs Cutting Back
- GuruFocus.com
-
10-K: GEMINI THERAPEUTICS, INC. /DE
- Edgar Online - (EDG = 10Q, 10K)
-
Gemini Therapeutics names interim CEO, announces job cuts
- Seeking Alpha
-
Biotech SPACS Have Hit the Skids
- GuruFocus.com
-
CCMP, PLIN and CNEY among mid-day movers
- Seeking Alpha
-
FREY, CDTX and BORR among pre market gainers
- Seeking Alpha
-
Gemini Therapeutics (GMTX) Investor Presentation - Slideshow
- Seeking Alpha
-
10-Q: GEMINI THERAPEUTICS, INC. /DE
- Edgar Online - (EDG = 10Q, 10K)
- Loading more headlines...
Press Releases on GMTX
-
Gemini Therapeutics Reports 2021 Financial Results
- BusinessWire - BZX
-
Gemini Therapeutics Provides Corporate Update
- BusinessWire - BZX
-
Gemini Therapeutics Provides GEM103 Program Update
- BusinessWire - BZX
-
Gemini Therapeutics Announces Poster Presentation at AAO 2021
- BusinessWire - BZX
-
Gemini Therapeutics to Participate in Upcoming Investor Conferences
- BusinessWire - BZX
-
Gemini Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- BusinessWire - BZX
-
Lightstone Ventures Raises $375 Million Fund
- PR Newswire - PRF
-
Gemini Therapeutics to Participate in the H.C. Wainwright Ophthalmology Conference
- BusinessWire - BZX
-
Gemini Therapeutics to Participate in the Jefferies Virtual Healthcare Conference
- BusinessWire - BZX
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com